ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 929,94
-0,22%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Healthcare Capital Corporation (HCCC)

  7. Healthcare Capital Corporation (HCCC) Actualités

HCCC

Healthcare Capital (HCCC)

Healthcare Capital Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HCCC
DateHeureSourceTitreSymboleSociété
14/02/202321h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HCCCHealthcare Capital Corporation
08/03/202212h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCCCHealthcare Capital Corporation
07/03/202222h22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:HCCCHealthcare Capital Corporation
18/02/202222h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HCCCHealthcare Capital Corporation
17/02/202216h11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HCCCHealthcare Capital Corporation
20/01/202212h45PR Newswire (US)Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast CancerNASDAQ:HCCCHealthcare Capital Corporation
14/01/202212h05Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:HCCCHealthcare Capital Corporation
03/01/202213h00PR Newswire (US)Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck CancerNASDAQ:HCCCHealthcare Capital Corporation
15/11/202121h57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HCCCHealthcare Capital Corporation
03/11/202118h00PR Newswire (US)Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)NASDAQ:HCCCHealthcare Capital Corporation
25/10/202114h25PR Newswire (US)Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary ObjectiveNASDAQ:HCCCHealthcare Capital Corporation
08/07/202113h51PR Newswire (US)Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...NASDAQ:HCCCHealthcare Capital Corporation
17/05/202122h38Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HCCCHealthcare Capital Corporation
15/04/202123h19Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HCCCHealthcare Capital Corporation
31/03/202120h35Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:HCCCHealthcare Capital Corporation
04/03/202123h30GlobeNewswire Inc.Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and WarrantsNASDAQ:HCCCHealthcare Capital Corporation
 Showing the most relevant articles for your search:NASDAQ:HCCC

Dernières Valeurs Consultées

LSE
101L
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés